ArticleMolecular and cellular pediatrics2026
MRI paving the way to diagnosis of acute lymphoblastic leukemia in children and adolescents - a retrospective observational study.
Article in Molecular and cellular pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrompt diagnosis of childhood acute lymphoblastic leukemia (ALL) remains a clinical challenge, particularly in children presenting with normal blood counts and musculoskeletal symptoms. With the increasing use of magnetic resonance imaging (MRI) in evaluating such complaints, bone marrow signal alterations may be detected before hematologic abnormalities appear. Previous studies have described characteristic MRI patterns in leukemia, suggesting potential for earlier recognition. This study aims to clarify the role of MRI in the diagnostic pathway of pediatric ALL and to define radiological findings that should prompt bone marrow examination. We retrospectively reviewed all patients diagnosed with ALL at our institution between 2006 and 2024 and included those who underwent MRI prior to diagnosis. Clinical data were collected, and all MRI studies were re-evaluated by an experienced pediatric radiologist.
resultsTwenty pediatric patients with ALL were included. Due to differing MRI protocols, the cohort was divided into two groups: one group (n = 17) underwent musculoskeletal imaging and one group (n = 3) underwent imaging of the trunk. Overall, MRI-detected bone marrow signal alterations contributed to diagnosis in 20 of 424 (4.7%) newly diagnosed pediatric ALL cases. More than one-third of patients (7/20; 35%) had a completely normal complete blood count (CBC) at presentation. Persistent bone pain was the leading symptom, preceding imaging in 18/20 cases. The mean time from symptom onset to MRI was 20.8 days (range 1-65), while the mean time from MRI to diagnosis was 18.4 days (range 0-180). In the musculoskeletal scans, all patients showed bone marrow signal alterations, predominantly T1-weighted (T1w) hypointensity (17/17) and proton-density-weighted (PDw) or T2-weighted short tau inversion recovery (T2w-STIR) hyperintensity (16/17). In the trunk scans, diffusion-weighted imaging revealed high DWI signal with low ADC values (3/3), and T2-weighted images demonstrated focal lesions (3/3).
conclusionMRI plays an important role in the diagnostic pathway of pediatric ALL, especially in patients with persistent musculoskeletal pain and normal blood counts. In our cohort, MRI examinations could initiate a rapid diagnostic process leading to ALL confirmation. Diffuse T1w hypointensity and diffusion restriction emerged as key imaging findings. A normal CBC should therefore not delay urgent oncologic assessment when the clinical presentation and MRI pattern are suspicious for leukemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.